Equally, reduced functionality of this pathway, for example when GSK3 activity is chronically raised due to insulin resistance, could make the beta cell more susceptible to oxidative, nitrosive or inflammatory damage, contributing to reduced beta cell mass and overt diabetes, with eventual requirement for insulin treatment. This evidence concerns the gene INS and diabetes mellitus.